• Skip to primary navigation
  • Skip to main content
  • Skip to footer

HepVu

HepVu

An estimated 3.5 million people in the U.S. are living with chronic Hepatitis C infection.

  • View the Map
  • Local Data
  • Find Services
  • News & Updates
  • Events
  • Tools & Resources
Home News & Updates Blogs & Q&As

Blogs & Q&As

Categories:

Awareness Days Blogs & Q&As HepVu Updates What's New in Viral Hepatitis Hep A Hep B Hep C Opioids COVID-19

November 16, 2022

Suzanne Davies on Managed Care Organizations and Medicaid

October 27, 2022

Dr. Mark Sulkowski on Relationship Between Viral Hepatitis, HIV & Liver Cancers

Read More

October 24, 2022

Dr. Heather Bradley and Boatemaa Ntiri-Reid on the Inaugural Viral Hepatitis Surveillance Report

Read More

August 11, 2022

Chari Cohen On The Importance Of Vaccinating Against Hepatitis B

Read More

July 28, 2022

HepVu’s One Question Series on Viral Hepatitis Elimination: People Who Inject Drugs

Read More

May 18, 2022

HepVu’s One Question Series on Viral Hepatitis Elimination: Testing

Read More

May 12, 2022

Dr. Rita Isabel Lechuga on National Hispanic Hepatitis Awareness Day

Read More

April 5, 2022

Leading Viral Hepatitis Groups Launch the Hep ElimiNATION Project

Read More

March 21, 2022

Combatting Hepatitis C Among People Who Use Drugs in Appalachia

Read More

March 21, 2022

Dr. John W. Ward on the Coalition for Global Hepatitis Elimination (CGHE)

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4

Sign up for HepVu updates.

Footer

AIDSVu HepVu

HepVu is presented by Emory University’s Rollins School of Public Health in partnership with Gilead Sciences, Inc.

  • About
  • FAQ
  • Data Methods
  • Datasets

Questions?
Info@HepVu.org

Media Inquiries
(202) 854-0480
Media@HepVu.org

Follow Us

  • Facebook
  • Twitter

© 2023 HepVu. All Rights Reserved.

  • Privacy Policy
  • Contact Us

Get HepVu in Your Inbox

Sign up to stay informed on new data, maps, expert Q&As, and infographics about Hepatitis C and opioids where you live.